Status:
UNKNOWN
Replacement of Fresh Embryo Transfers (ETs) by Frozen Embryo Transfers (FETs) Using Vitrification
Lead Sponsor:
Yazd Research & Clinical Center for Infertility
Conditions:
In Vitro Fertilization
Eligibility:
FEMALE
18-38 years
Phase:
PHASE1
PHASE2
Brief Summary
Cryopreservation of all embryos and transferring them subsequently in assisted reproductive technology (ART) cycles to improve outcome.
Detailed Description
All patients in the initial cohort were treated with long protocol for ovarian stimulation. For pituitary down-regulation, patients were treated with daily administration of 0.5 mg buserelin (suprefac...
Eligibility Criteria
Inclusion
- age \< 38
- normal day 3 FSH
- classified as high risk for OHSS
- has ≥ 15 follicles with a mean diameter ≥ 12 mm per each ovary
- E2 levels on the day of hCG administration \> 3000 pg/mL
- undergoing her first assisted reproduction treatment cycle
Exclusion
- who does not have good-quality embryos appropriate for cryopreservation
Key Trial Info
Start Date :
August 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2009
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT00823121
Start Date
August 1 2008
End Date
December 1 2009
Last Update
January 20 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
: Research and clinical center for infertility
Yazd, Yazd Province, Iran, 8916877391